February 6, 2023
Prevacus
Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Florida Business News

Florida News Releases

Florida Trend Video Pick

New Florida-developed strawberry becomes a national sensation
New Florida-developed strawberry becomes a national sensation

Gov. DeSantis proposes record budget; Visa-processing and inflation ding state tourism; December beats revenue projections; A Florida Gulf Coast invasion; UF/IFAS's new fruit is a hit.

Video Picks | Viewpoints@FloridaTrend

Ballot Box

Should Floridians selling real estate tell buyers if the property has been damaged from flooding?

  • Yes
  • No
  • Other (Please share your comments in the comment section below)

See Results

Florida Trend Media Company
490 1st Ave S
St Petersburg, FL 33701
727.821.5800

© Copyright 2023 Trend Magazines Inc. All rights reserved.